1-1 of 1
Stefan Krause, MD., Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Y-90 Ibritumomab Tiuxetan as Consolidation Following Three Cycles of Fludarabine-Cyclophosphamide-Rituximab Chemoimmunotherapy in Patients with Relapsed Follicular, Indolent or Mantle-Cell Lymphoma: A Prospective “Dose”-Finding Study.

Christoph von Schilling, MD, Kathleen Schwarz, MD, Georg Hess, MD., Ph.D., Andreas Viardot, MD, Michael Sandherr, MD, Stefan Krause, MD., Ph.D., Jan P. Simon, MD, Ph.D., Nadine Roethling, Christian Peschel, MD, Ph.D., Markus Schwaiger, MD, Ph.D., Klemens Scheidhauer, MD, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3426.
https://doi.org/10.1182/blood.V110.11.3426.3426
Published: 2007